SYSTEM-DOB-PRECIO-MEDICATIONS-Spain
Today I found the news by chance and I share it, he speaks of the well -known Ozempic for putting an example and why type 2 diabetics have a hard time finding it in pharmacies, that it is very shameless that he is always exhausted.At the time I was prescribed by the endocrine and it was impossible to access him.
What is the double -price system that will be applied to medicines in Spain?
The Ministry of Health of the Government
Spain has proposed this week the implementation of a double system
of price in pharmacies for certain drugs whose high demand is
causing supply problems.The measure would apply
temporarily to medications when there is shortage for uses not indicated
nor financed by public health, as is currently with the
AntidiabeticOzempic, used outside prescription to lose weight.
Ozempic,
an originally indicated medication for the treatment of
Type 2 diabetes, has become one of the most demanded drugs
In Spain.According to statista data published in May 2025,
laboratories invoiced almost 485 million euros in 2024 for the sale
of Ozempic and its analogues, a figure 21 times higher than the registered
In 2019. This exponential boom in its consumption is closely
relating to its growing useas treatment for obesityAnd it is aSupply problem for diabetic patients who need it.
In this context, Health launched an order Health points out that the double price will be a temporary measure that is list will be those who are part ofThe pharmaceutical provision of the National Health System (SNS), that may have a "significant" use for unsigned indications or outside those approved in their technical file. For continuing with Ozempic's example, pharmacies This double price will be put only when it has been prescribed to In short, the double -price system proposed It should be noted that the health proposal has not entered into force
Ministerial last Tuesday, July 8, 2025. Although in the document
They did not cite any concrete drugs, they did spoke of «recurringSupply problemsof certain medications for its use in indications not
authorized or financed ”, something that is happening with Ozempic and its
AnaloguesThe Spanish Ministry proposed "the implementation of a
double price system for these medications »to preserve your
Availability in the indications financed by the government of
Spain.The double price will be temporary
It will take on the medications that are determined.If the proposal continues
Go ahead, we will still have to determine which drugs will be affected,
Although Ozempic starts as one of the main candidates.The
medications that are included in the
They can sell it as a medicine for other non -indicated purposes, but
They must make their price more expensive.The cost must be similar to that of others
Drugs used against obesity not financed, such asWegovyThe price of this other medicine in Spain ranges from € 180
for the initial doses and the € 292 per month for those of
Maintenance, according to data contrasted in July 2025.
an out of your indication or financing.However, if I know
reduce the high demand of Ozempic and the like and there would be enough
Stock for antidiabetic use, the double price would be withdrawn.According to
explains health, the exceptional measure is protected by article 94.7 of
the Law of Guarantees and Rational Use of Medicines, which indicates that
The government must make decisions about the price in situations of
shortage for reasons of general interest.
Introducing the medications of the indicated SNS has the following
goals:
SNS has a more accessible price for people who truly
They need, while the use not indicated or not funded is more
expensive (even if you go with a recipe).
that patients have access to essential medicines in
Spanish pharmacies and avoid the problem of shortage.
Not a draft, but a public consultation after project of order
ministerial.Until July 22, 2025, citizenship,
organizations and associations can send their opinions about the
Double price system for drugs raised via mail
electronicParticipation innovation.